Meiji Yasuda Life Insurance Co cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 44.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,633 shares of the semiconductor company’s stock after selling 1,320 shares during the period. Meiji Yasuda Life Insurance Co’s holdings in Synopsys were worth $728,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Sankala Group LLC purchased a new stake in Synopsys during the fourth quarter valued at about $25,000. Elevation Wealth Partners LLC raised its holdings in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the period. Osbon Capital Management LLC acquired a new position in shares of Synopsys in the 2nd quarter valued at about $25,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Synopsys in the 4th quarter valued at about $28,000. Finally, IMG Wealth Management Inc. purchased a new stake in shares of Synopsys during the 2nd quarter worth about $28,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
SNPS has been the subject of a number of research analyst reports. Zacks Research downgraded shares of Synopsys from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 21st. UBS Group set a $570.00 price objective on shares of Synopsys in a research note on Thursday. KeyCorp reissued an “overweight” rating on shares of Synopsys in a research report on Wednesday, August 19th. Robert W. Baird raised shares of Synopsys from a “neutral” rating to an “outperform” rating and raised their target price for the company from $558.00 to $560.00 in a research note on Thursday. Finally, Mizuho reduced their target price on shares of Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a report on Thursday. Twelve investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $561.28.
Insiders Place Their Bets
In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.
Synopsys Stock Performance
Synopsys stock opened at $442.61 on Friday. The firm has a market capitalization of $84.82 billion, a PE ratio of 78.20, a price-to-earnings-growth ratio of 2.60 and a beta of 1.23. Synopsys, Inc. has a one year low of $366.00 and a one year high of $615.79. The stock’s 50 day moving average price is $416.64 and its 200 day moving average price is $440.13. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.32 and a current ratio of 1.34.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. Synopsys’s revenue for the quarter was up 42.4% on a year-over-year basis. During the same quarter last year, the company earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 11.03 EPS for the current fiscal year.
Trending Headlines about Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Strong Q3 performance: Synopsys reported adjusted earnings of $3.91 per share versus expectations of $3.67, while revenue reached $2.48 billion, up 42.4% year over year and ahead of estimates. Strength in electronic design automation (EDA) and the Ansys acquisition supported the results. SNPS Q3 Earnings Beat Estimates on EDA and Ansys Strength
- Positive Sentiment: Higher outlook and AI momentum: Management raised fiscal 2026 guidance, citing accelerating EDA demand, recovering Design IP activity, interest in agentic AI and additional opportunities from integrating Ansys. Fiscal 2026 EPS guidance is $15.04–$15.10, with revenue guidance reportedly raised to approximately $9.72 billion. SNPS Q3 Earnings Call Highlights EDA Acceleration, Outlook Raised
- Positive Sentiment: Analyst and strategic support: Goldman Sachs, Benchmark and Needham reaffirmed Buy ratings, with price targets ranging from $570 to $600. Elliott Investment Management also reportedly built a multibillion-dollar position, betting Synopsys can narrow its discount to peers. Elliott Bets Multibillion-Dollar Position on Closing Synopsys’ Peer Discount
- Neutral Sentiment: Commentators view Synopsys as a key supplier to major technology companies, including Nvidia, and believe Ansys has strengthened its competitive moat; however, the acquisition’s full contribution depends on successful integration and future synergies. SNPS in Right Place, Right Time?
- Negative Sentiment: Valuation and peer concerns: Following the earnings rally, investors are refocusing on valuation, with Synopsys trading at a high earnings multiple. A comparison with PDF Solutions also highlighted stronger growth and margin improvement at the smaller rival, potentially limiting near-term enthusiasm for SNPS. SNPS vs. PDFS: Which Semiconductor Software Stock Has an Edge?
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
